Search Materials | CDC FTBR

Filter your results

Clear All Filters

Showing 41 - 20 of 1138 Results

Number of items to view

Filter Your Results

Category

Audience

Format

Language

Title	Year
Comparison of a Whole-Blood Interferon Gamma Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium Tuberculosis Infection. Journal of the American Medical Association. 286(14):1740-1747,October 10, 2001. This report provides findings from a study designed to compare a whole-blood interferon gamma assay, the QuantiFERON-TB test, with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection and to identify factors associated with discordance between the tests.	2001
TB Net Clinic Systems Manual This information packet discusses the use of a clinician-based referral and tracking system for migrant workers with TB. It includes samples of a pocket-sized bilingual (English/Spanish) treatment record for migrant workers.	2001
Tuberculosis This monograph discusses the history of TB, the search for TB treatment and diagnostic methods, and its resurgence, including the emergence of multiple drug resistant (MDR) strains of TB.	2001
Tuberculosis Case Management for Nurses: Self-Study Modules These four self-study modules cover public health and public nursing issues, the fundamentals of TB case management, leadership skills of the nurse case manager, and case management of pediatric patients with TB.	2001
Prospectus: Global TB Drug Facility: A Global Mechanism to Ensure Uninterrupted Access to Quality TB Drugs for DOTS Implementation This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs. International Agencies	2001
Treatment of Latent Tuberculosis Infection (Preventive Therapy) This fact sheet, available online or via fax only, discusses who should receive treatment, regimen options for HIV-infected persons as well as those not infected, and monitoring.	2001
Global TB Drug Facility This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy. International Agencies	2001
Prospectus: Global TB Drug Facility: A Global Mechanism to Ensure Uninterrupted Access to Quality TB Drugs for DOTS Implementation This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF). International Agencies	2001
MMWR: Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations--United States, 2001 This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.	2001
MMWR: Cluster of Tuberculosis Cases Among Exotic Dancers and Their Close Contacts--Kansas, 1994-2000 This report describes the results of the investigation of a cluster of TB cases that occurred in Kansas from 1994 to 2000 among women with a history of working as exotic dancers and persons who were close contacts of the dancers.	2001
World TB Day--March 24, 2001. Morbidity and Mortality Weekly Report. 50(11):201, March 24, 2001 This announcement gives a brief overview of World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating TB.	2001
MMWR: Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection--New York and Georgia, 2000 This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.	2001
TB Simulated Patients: A Training and Resource for the Contact Investigation Interview This manual presents a role-play-based curriculum on how to conduct a contact investigation for persons with TB. It provides scripts and evaluation forms for each role-play session.	2001
What Does a Negative TB Skin Test Mean? This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.	2001
World TB Day 2001 Highlights This report highlights the accomplishments of World TB Day 2001. Community Leaders	2001
Knowing TB: Essential Knowledge for the General Public in HIV Epidemic Areas This booklet presents the frequent misconceptions and beliefs about TB in relation to HIV/AIDS. The contents are presented in a question and answer format using simple language with some photos from the field. This booklet also serves as a material for community TB training. Community Leaders	2001
Tuberculin Skin Test Ruler This straight-edge ruler is used to measure the induration of an individual's reaction to the tuberculin skin test. The white ruler provides tips on how to read the test and a space for local contact information to be inscribed with a permanent marker.	2002
Designing a Tuberculosis Standardized Patient Program for Medical Students This book is designed for medical school faculty who are interested in implementing a TB standardized patient program for medical school students. Medical and Nursing School Students Policy Makers	2002
Interventions for Tuberculosis Control and Elimination This book discusses the medical treatments for TB as a means of prevention and elimination. It discusses typical first- and second-line treatments of TB, the use of prophylactic treatment in people exposed to TB, and the effectiveness of BCG vaccination in TB prevention.	2002
Research Methods for Promotion of Lung Health: A Guide to Protocol Development for Low-Income Countries This book provides an overview of lung health and discusses epidemiology, research methods, and the use of research results.	2002